No serious adverse effects have been consistently reported in clinical trials [1], [7]
van der Klaauw AA, Croizier S, Mendes de Oliveira E, Stadler LKJ, Park S, Kong Y, Banton MC, Tandon P, Hendricks AE, Keogh JM, Riley SE, Papadia S, Henning E, Bounds R, Bochukova EG, Mistry V, O'Rahilly S, Simerly RB, Minchin JEN, Barroso I, Jones EY, Bouret SG, Farooqi IS
This gap between medically eligible patients and financially treated patients keeps the semaglutide weight management drug market below its full potential, because wider need alone does not translate into sustained use when coverage is fragmented and the monthly cost remains high
Causing side effects such as, reduced appetite, slower digestion, and weight loss
Reducir el agotamiento del glucgeno muscular
J Transl Int Med